CEBPA and acute myeloid leukemia: For example, AML with germline CEBPA mutations, included in Table 3 as the first entry in the familial AML and myelodysplastic neoplasm group, has a natural history of relapsed AML, which can only be treated to prevent future relapses by an allogeneic HSCT [163].